6 completed. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Torulopsis: new trials by email Literature Review of Torulopsis trials Research Report on Torulopsis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy Volunteers CanProFem-AK - Candidosis Vaginal | Phase 1 | Completed | Industrial Microbiology LLP | 20 | 2024-06-01 | 2024-08-02 |
| A Bioequivalence Study of APX001 High-load and Low-load Tablets APX001, APX001A - Invasive Fungal Infections | Phase 1 | Completed | Basilea Pharmaceutica | 18 | 2021-03-02 | 2024-07-11 |
| Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis NDV-3A, NDV-3, Placebo - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Completed | NovaDigm Therapeutics, Inc. | 188 | 2013-07-01 | 2018-07-18 |
| Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida NDV-3 investigational vaccine - Staphylococcal Infections, Candidiasis | Phase 1 | Completed | NovaDigm Therapeutics, Inc. | 40 | 2011-01-01 | 2012-05-22 |
| An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates Micafungin - Candida | Phase 1 | Completed | Astellas Pharma Inc | 13 | 2007-08-01 | 2013-03-06 |
| Study With Candida Antigen for Treatment of Warts Candida Antigen - Warts, HPV | Phase 1 | Completed | University of Arkansas | 18 | 2007-02-01 | 2011-01-25 |
Candidiasis, Vulvovaginal (2) · Candidiasis (1) · Invasive Fungal Infections (1) · Staphylococcal Infections (1) · Warts (1)
Infections (5) · Bacterial Infections and Mycoses (4) · Mycoses (4) · Candidiasis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Urogenital Diseases (2) · Vaginal Diseases (2) · Vaginitis (2) · Vulvar Diseases (2) · Vulvitis (2) · Vulvovaginitis (2) · Bacterial Infections (1)
APX001A (1) · Micafungin (1) · PRA1 protein, Candida albicans (1)
NovaDigm Therapeutics, Inc. (2) · Astellas Pharma Inc (1) · Basilea Pharmaceutica (1) · Industrial Microbiology LLP (1) · University of Arkansas (1)
United States (5) · Kazakhstan (1)
John P. Hennessey, Jr., Ph.D. (1) · Marc Engelhardt (1) · Mayumi Nakagawa, MD, PhD (1)